# Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

> **NCT00370045** · PHASE4 · UNKNOWN · sponsor: **LifeBridge Health** · enrollment: 200 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Bivalirudin with and without eptifibatide

## Key facts

- **NCT ID:** NCT00370045
- **Lead sponsor:** LifeBridge Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (—)
- **Last updated:** 2006-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370045, "Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00370045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*